BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ryan E, Amato D, MacKenzie JJ, Sidransky E, Lopez G. Parkinsonism in Patients with Neuronopathic (Type 3) Gaucher Disease: A Case Series. Mov Disord Clin Pract 2020;7:834-7. [PMID: 33043079 DOI: 10.1002/mdc3.13031] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Weinreb NJ, Goker-alpan O, Kishnani PS, Longo N, Burrow TA, Bernat JA, Gupta P, Henderson N, Pedro H, Prada CE, Vats D, Pathak RR, Wright E, Ficicioglu C. The diagnosis and management of Gaucher disease in pediatric patients: Where do we go from here? Molecular Genetics and Metabolism 2022. [DOI: 10.1016/j.ymgme.2022.03.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Roh J, Subramanian S, Weinreb NJ, Kartha RV. Gaucher disease – more than just a rare lipid storage disease. J Mol Med. [DOI: 10.1007/s00109-021-02174-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Franco G, Lazzeri G, Di Fonzo A. Parkinsonism and ataxia. J Neurol Sci 2021;:120020. [PMID: 34711421 DOI: 10.1016/j.jns.2021.120020] [Reference Citation Analysis]
4 Daykin EC, Ryan E, Sidransky E. Diagnosing neuronopathic Gaucher disease: New considerations and challenges in assigning Gaucher phenotypes. Mol Genet Metab 2021;132:49-58. [PMID: 33483255 DOI: 10.1016/j.ymgme.2021.01.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]